CTIM-06. CLINICAL EFFICACY AND BIOMARKER ASSESSMENT OF VT1021, A CD36/CD47 DUAL-TARGETING AGENT, IN RECURRENT GLIOBLASTOMA - Ahluwalia, Manmeet; Battiste, James; Bockorny, Bruno; Bullock, Andrea; Patel, Manish; Wen, Patrick; Shepard, Dale; Vaickus, Lou; Vincent, Melanie; Chen, Jian jenny; Wang, Suming; Watnick, Randolph; et al. (Neuro-oncology (Charlottesville, Va.), 2021)